Andrographolide |
Influence on cell proliferation in tumor tissue in presence of gemcitabine |
Tumor volume |
15.00 mg/kg |
AsPC-1 (xenograft) |
Mus musculus |
BALB/c |
|
|
Andrographolide |
Influence on cell proliferation in tumor tissue in presence of gemcitabine |
Tumor weight |
15.00 mg/kg |
AsPC-1 (xenograft) |
Mus musculus |
BALB/c |
|
|
Andrographolide |
Influence on cell proliferation in tumor tissue in presence of gemcitabine |
Immunostaining |
15.00 mg/kg |
AsPC-1 (xenograft) |
Mus musculus |
BALB/c |
|
|
Andrographolide |
Influence on cell proliferation in tumor tissue in presence of gemcitabine |
TUNEL |
15.00 mg/kg |
AsPC-1 (xenograft) |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on liver damage |
Body weight |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on liver damage |
Immunostaining |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on liver damage |
Immunostaining |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on CCl4-induced inflammation |
RT-qPCR |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
STAT3 |
|
Andrographolide derivative |
Influence on CCl4-induced inflammation |
RT-qPCR |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on CCl4-induced inflammation |
RT-qPCR |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on CCl4-induced inflammation |
RT-qPCR |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on CCl4-induced inflammation |
RT-qPCR |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on CCl4-induced inflammation |
RT-qPCR |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|
Andrographolide derivative |
Influence on CCl4-induced inflammation |
RT-qPCR |
30.00 mg/kg |
liver |
Mus musculus |
BALB/c |
|
|